Ning Feng 1/23/25 Ning Feng 1/23/25 AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology Read More Guest User 1/16/25 Guest User 1/16/25 JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson Read More Guest User 1/16/25 Guest User 1/16/25 ‘The bar has risen’: China’s biotech gains push US companies to adapt Read More Guest User 1/14/25 Guest User 1/14/25 Biopharma Deals Start Flowing at JPM25—With One Dwarfing Last Year’s Activity Read More Guest User 1/13/25 Guest User 1/13/25 The Top 10 Biopharma M&A Deals of 2024 Read More Ning Feng 11/14/24 Ning Feng 11/14/24 Merck signs up to $3.3 billion cancer drug deal with China-based LaNova Read More Guest User 11/13/24 Guest User 11/13/24 BioNTech to Acquire Biotheus to Boost Oncology Strategy Read More Guest User 11/7/24 Guest User 11/7/24 VC Aditum Bio hatches autoimmune-focused Oblenio Bio with asset from Chinese biotech Read More Guest User 10/31/24 Guest User 10/31/24 AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics Read More Guest User 10/29/24 Guest User 10/29/24 Novartis' $2.9B MorphoSys bet stumbles as safety signal delays filing by years Read More Guest User 10/29/24 Guest User 10/29/24 GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline Source: GSK plc Read More Guest User 10/8/24 Guest User 10/8/24 US Venture Capital Opens Path to Funding for China Biotech Firms Read More Guest User 8/29/24 Guest User 8/29/24 Can China Tech Find a Home in Silicon Valley? Read More Guest User 8/27/24 Guest User 8/27/24 Duality plans Hong Kong IPO to fund trials of BioNTech-partnered ADCs and beyond Read More Guest User 8/16/24 Guest User 8/16/24 Genentech to shut down cancer immunology research department amid broader R&D rethink Source: Genentech/Roche Read More Guest User 2/7/24 Guest User 2/7/24 AIM-HI Accelerator Fund celebrates Yiviva's milestone collaboration with AstraZeneca China, furthering technology platforms for multiple cancers Source: Yiviva Read More Ning Feng 11/10/23 Ning Feng 11/10/23 Fierce Pharma Asia—AstraZeneca's GLP-1 play; Takeda's cancer drug approval; BioNTech's bispecific deal Read More Tianjun Song 5/17/23 Tianjun Song 5/17/23 Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor Read More Tianjun Song 4/4/23 Tianjun Song 4/4/23 BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors Read More Tianjun Song 3/20/23 Tianjun Song 3/20/23 BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications Read More Older Posts
Ning Feng 1/23/25 Ning Feng 1/23/25 AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology Read More
Guest User 1/16/25 Guest User 1/16/25 JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson Read More
Guest User 1/16/25 Guest User 1/16/25 ‘The bar has risen’: China’s biotech gains push US companies to adapt Read More
Guest User 1/14/25 Guest User 1/14/25 Biopharma Deals Start Flowing at JPM25—With One Dwarfing Last Year’s Activity Read More
Ning Feng 11/14/24 Ning Feng 11/14/24 Merck signs up to $3.3 billion cancer drug deal with China-based LaNova Read More
Guest User 11/13/24 Guest User 11/13/24 BioNTech to Acquire Biotheus to Boost Oncology Strategy Read More
Guest User 11/7/24 Guest User 11/7/24 VC Aditum Bio hatches autoimmune-focused Oblenio Bio with asset from Chinese biotech Read More
Guest User 10/31/24 Guest User 10/31/24 AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics Read More
Guest User 10/29/24 Guest User 10/29/24 Novartis' $2.9B MorphoSys bet stumbles as safety signal delays filing by years Read More
Guest User 10/29/24 Guest User 10/29/24 GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline Source: GSK plc Read More
Guest User 10/8/24 Guest User 10/8/24 US Venture Capital Opens Path to Funding for China Biotech Firms Read More
Guest User 8/27/24 Guest User 8/27/24 Duality plans Hong Kong IPO to fund trials of BioNTech-partnered ADCs and beyond Read More
Guest User 8/16/24 Guest User 8/16/24 Genentech to shut down cancer immunology research department amid broader R&D rethink Source: Genentech/Roche Read More
Guest User 2/7/24 Guest User 2/7/24 AIM-HI Accelerator Fund celebrates Yiviva's milestone collaboration with AstraZeneca China, furthering technology platforms for multiple cancers Source: Yiviva Read More
Ning Feng 11/10/23 Ning Feng 11/10/23 Fierce Pharma Asia—AstraZeneca's GLP-1 play; Takeda's cancer drug approval; BioNTech's bispecific deal Read More
Tianjun Song 5/17/23 Tianjun Song 5/17/23 Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor Read More
Tianjun Song 4/4/23 Tianjun Song 4/4/23 BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors Read More
Tianjun Song 3/20/23 Tianjun Song 3/20/23 BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications Read More